Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Rheumatoid Arthritis

  Free Subscription


Articles published in Clin Exp Immunol

Retrieve available abstracts of 34 articles:
HTML format



Single Articles


    July 2024
  1. NOZAKI Y, Akiba H, Akazawa H, Yamazawa H, et al
    Inhibition of the TIM-1 and -3 Signaling Pathway Ameliorates Disease in a Murine Model of Rheumatoid Arthritis.
    Clin Exp Immunol. 2024 Jul 8:uxae056. doi: 10.1093.
    PubMed     Abstract available


    May 2024
  2. KHANFAR E, Olasz K, Gal S, Gajdocsi E, et al
    Splenectomy at early stage of autoimmune arthritis delayed inflammatory response and reduced joint deterioration in mice.
    Clin Exp Immunol. 2024;216:240-251.
    PubMed     Abstract available


    February 2024
  3. IWAI T, Ohyama A, Osada A, Nishiyama T, et al
    Role of inter-alpha-trypsin inhibitor heavy chain 4 and its citrullinated form in experimental arthritis murine models.
    Clin Exp Immunol. 2024;215:302-312.
    PubMed     Abstract available


    December 2023
  4. FORNARO M, Girolamo F, Cacciapaglia F, Carabellese G, et al
    Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity.
    Clin Exp Immunol. 2023;214:94-102.
    PubMed     Abstract available


    July 2023
  5. MORALES-NUNEZ JJ, Munoz-Valle JF, Garcia-Chagollan M, Cerpa Cruz S, et al
    Aberrant B cell activation and B cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment.
    Clin Exp Immunol. 2023 Jul 19:uxad076. doi: 10.1093.
    PubMed     Abstract available


  6. SUN HG, Jiang Q, Fan WJ, Shen XY, et al
    TAGAP Activates Th17 Cell Differentiation by Promoting RhoA and NLRP3 to Accelerate Rheumatoid Arthritis Development.
    Clin Exp Immunol. 2023 Jul 17:uxad084. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  7. ZHOU L, Wang H, Zhang H, Wang F, et al
    Diagnostic markers and potential therapeutic agents for Sjogren's syndrome screened through multiple machine learning and molecular docking.
    Clin Exp Immunol. 2023;212:224-238.
    PubMed     Abstract available


  8. HASHIMOTO T, Yoshida K, Yokoyama Y, Hashimoto N, et al
    Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.
    Clin Exp Immunol. 2023 Jun 4:uxad064. doi: 10.1093.
    PubMed     Abstract available


    May 2023
  9. WU XN, Gao ZW, Yang L, Zhang J, et al
    CD5L aggravates rheumatoid arthritis progression via promoting synovial fibroblasts proliferation and activity.
    Clin Exp Immunol. 2023 May 16:uxad054. doi: 10.1093.
    PubMed     Abstract available


    April 2023
  10. RIVIERE E, Chivasso C, Pascaud J, Bechara R, et al
    Hyperosmolar environment and salivary gland epithelial cells increase extra-cellular matrix remodeling and lymphocytic infiltration in Sjogren's syndrome.
    Clin Exp Immunol. 2023;212:39-51.
    PubMed     Abstract available


    March 2023
  11. LARAGIONE T, Harris C, Gulko PS
    Combination therapy of a TRPV2 agonist with a TNF inhibitor achieves sustained suppression of disease severity and reduced joint damage.
    Clin Exp Immunol. 2023;211:233-238.
    PubMed     Abstract available


  12. CHO S, Jang E, Yoon T, Hwang H, et al
    A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced arthritis in murine models.
    Clin Exp Immunol. 2023;211:31-45.
    PubMed     Abstract available


    January 2023
  13. ZONG M, Cheng Y, Ye B, Chen S, et al
    Preparation of Mesoporous Silica Nanocarriers Targeting Glucose-6-Phosphate Isomerase Inhibition and Application in the Treatment of Rheumatoid Arthritis.
    Clin Exp Immunol. 2023 Jan 4:uxac116. doi: 10.1093.
    PubMed     Abstract available


    November 2022
  14. WEYAND CM, Wu B, Huang T, Hu Z, et al
    Mitochondria as disease-relevant organelles in rheumatoid arthritis.
    Clin Exp Immunol. 2022 Nov 24:uxac107. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  15. VALLI A, Kuuliala K, Virtanen A, Kuuliala A, et al
    Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response.
    Clin Exp Immunol. 2022 Sep 17. pii: 6702616. doi: 10.1093.
    PubMed     Abstract available


    August 2022
  16. ZHENG L, Xu L, Hu F, Xue J, et al
    Elevated expression of TAM receptor tyrosine kinase in synovial fluid and synovial tissue of rheumatoid arthritis.
    Clin Exp Immunol. 2022 Aug 11. pii: 6661266. doi: 10.1093.
    PubMed     Abstract available


  17. WANG W, Xiang T, Yang Y, Wang Z, et al
    E3 Ubiquitin Ligases STUB1 Contributes to the Th17/Treg Imbalance via the Ubiquitination of Aryl Hydrocarbon Receptor in Rheumatoid Arthritis.
    Clin Exp Immunol. 2022 Aug 9. pii: 6659032. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  18. RUSCITTI P, Berardicurti O, Di Cola I, Di Muzio C, et al
    The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.
    Clin Exp Immunol. 2022;208:95-102.
    PubMed     Abstract available


  19. RUSCITTI P, Berardicurti O, Di Cola I, Di Muzio C, et al
    The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.
    Clin Exp Immunol. 2022;208:95-102.
    PubMed     Abstract available


  20. XIE Y, Jiang X, Wang P, Zheng X, et al
    SR-A neutralizing antibody: potential drug candidate for ameliorating osteoclastogenesis in rheumatoid arthritis.
    Clin Exp Immunol. 2022;207:297-306.
    PubMed     Abstract available


    January 2022
  21. QIAN S, Xu J, Zhao S, Yang P, et al
    CMTM6: increased circulating level and up-regulated expression in labial salivary glands in patients with primary Sjogren's syndrome.
    Clin Exp Immunol. 2022;207:65-71.
    PubMed     Abstract available


    December 2021
  22. PATEL S, Ramnoruth N, Wehr P, Rossjohn J, et al
    Evaluation of a fit-for-purpose assay to monitor antigen-specific functional CD4+ T cell subpopulations in rheumatoid arthritis using flow-cytometry based peptide-MHC class-II tetramer staining.
    Clin Exp Immunol. 2021 Dec 5. pii: 6453380. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  23. OLSSON AM, Povoleri GAM, Somma D, Ridley ML, et al
    miR-155 overexpressing monocytes resemble HLA highISG15 + synovial tissue macrophages from patients with rheumatoid arthritis and induce polyfunctional CD4+ T cell activation.
    Clin Exp Immunol. 2021 Nov 30. pii: 6446881. doi: 10.1093.
    PubMed     Abstract available


  24. HANLON MM, Canavan M, Barker BE, Fearon U, et al
    Metabolites as drivers and targets in Rheumatoid Arthritis.
    Clin Exp Immunol. 2021 Nov 27. pii: 6445033. doi: 10.1093.
    PubMed     Abstract available


  25. SHIMOJIMA Y, Ichikawa T, Kishida D, Takamatsu R, et al
    Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.
    Clin Exp Immunol. 2021;206:184-195.
    PubMed     Abstract available


    September 2021
  26. TANG Y, Bai Z, Qi J, Lu Z, et al
    Altered peripheral B lymphocyte homeostasis and functions mediated by IL-27 via activating the mTOR signaling pathway in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2021 Sep 24. doi: 10.1111/cei.13663.
    PubMed     Abstract available


    August 2021
  27. NOCTURNE G, Ly B, Paoletti A, Pascaud J, et al
    Long-term exposure to monoclonal anti-TNF is associated with an increased risk of lymphoma in BAFF-transgenic mice.
    Clin Exp Immunol. 2021;205:169-181.
    PubMed     Abstract available


    June 2021
  28. ROOS LJUNGBERG K, Martinsson K, Wettero J, Svard A, et al
    Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients.
    Clin Exp Immunol. 2021;204:344-351.
    PubMed     Abstract available


  29. TIAN J, Zhou D, Xiang L, Liu X, et al
    MiR-223-3p inhibits inflammation and pyroptosis in monosodium urate-induced rats and fibroblast-like synoviocytes by targeting NLRP3.
    Clin Exp Immunol. 2021;204:396-410.
    PubMed     Abstract available


    May 2021
  30. YAMANE K, Nakamura H, Hamasaki M, Minei Y, et al
    Immune complexome analysis reveals the presence of immune complexes and identifies disease-specific immune complex antigens in saliva samples from patients with Sjogren's syndrome.
    Clin Exp Immunol. 2021;204:212-220.
    PubMed     Abstract available


    April 2021
  31. ISAILOVIC N, Ceribelli A, Cincinelli G, Vecellio M, et al
    Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2021 Apr 26. doi: 10.1111/cei.13609.
    PubMed     Abstract available


    March 2021
  32. OSADA A, Matsumoto I, Mikami N, Ohyama A, et al
    Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
    Clin Exp Immunol. 2021;203:385-399.
    PubMed     Abstract available


  33. HALPERT G, Halperin Sheinfeld M, Monteran L, Sharif K, et al
    The tellurium-based immunomodulator, AS101 ameliorates adjuvant-induced arthritis in rats.
    Clin Exp Immunol. 2021;203:375-384.
    PubMed     Abstract available


    February 2021
  34. GLENNON-ALTY L, Moots RJ, Edwards SW, Wright HL, et al
    Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression.
    Clin Exp Immunol. 2021;203:151-159.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.